Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 161   

Articles published

MRK 58.53 -0.01 (-0.01%)
price chart
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead
Pharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE). Meanwhile biotech investors ...
Earnings Whispers - Merck & Co., Inc. (MRK) To Report Q2 Earnings Today  Bidness ETC
Merck & Co., Inc. (MRK) Releases FY15 Earnings Guidance  Junior College
Merck & Co., Inc. (MRK) Issues FY15 Earnings Guidance
Merck & Co. logo Merck & Co., Inc. (NYSE:MRK) updated its FY15 earnings guidance on Tuesday. The company provided EPS guidance of $3.45-3.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.44, MarketBeat.
Merck & Co. Lifted to Strong-Buy at Vetr Inc. (MRK)  Watch List News
Zacks Rating on Merck & Company, Inc.
As much as 13 analysts have advised buy on Merck & Company, Inc. (NYSE:MRK) with an average broker rating of 2.08. Research Analysts at Zacks has the shares a rating of 3, which implies that the firms recommendation is Neutral on the company.
ABLYNX SIGNIFICANTLY EXPANDS ITS IMMUNO-ONCOLOGY COLLABORATION WITH MERCK & CO ...
"The expansion of this ongoing collaboration with Ablynx allows us to increase our ability to evaluate the potential of more immune checkpoint targets for the treatment of cancer.
Merck & Co., Inc. - Product Pipeline Review - 2015
This report provides comprehensive information on the current therapeutic developmental pipeline of Merck & Co., Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...
Active Stocks in Review: Merck & Co. Inc. (NYSE:MRK), Magnum Hunter Resources ...
Merck & Co., known as MSD outside the United States and Canada, recently declared that Pamela J. Craig, stepped down chief financial officer of Accenture, and Dr.
Merck & Co. Inc. (MRK) Closes 1.77% Up on the Day for July 29
Dow Jones component Merck & Co. Inc. (MRK) saw its stock move 1.77% to $58.54, representing a per-share move of $1.02, on volume of 12.62 million shares for Wednesday.
Active Stocks Trader's Buzzers: Merck & Co. Inc. (NYSE:MRK), MetLife, Inc ...
Merck & Co., known as MSD outside the United States and Canada, declared that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of the ...
Allergan PLC On A Roll; Buys Merck & Co. Migraine Drug Rights
Allergan PLC (NYSE:AGN) announced on Tuesday it has entered into an agreement with Merck & Co., Inc. (NYSE:MRK), under which it would acquire exclusive global rights to two of Merck's migraine drugs currently in experimental stages, MK-1602 and ...
Merck & Co. Inc. (NYSE:MRK) and Allergan plc (AGN) Signs Into an ...  StreetWise Report
Merck & Co., Inc. (NYSE:MRK) Sells Its Migraine Drugs To Allergan PLC ...  USMarketsDaily (blog)
Shares of Merck & Company, Inc. (NYSE:MRK) Sees Large Inflow of Net Money Flow
Merck & Company, Inc. (NYSE:MRK) had a weak trading session and its shares were last down at $57.41, down -0.66% or -1.14 points.